A detailed history of Jain Global LLC transactions in Geron Corp stock. As of the latest transaction made, Jain Global LLC holds 46,950 shares of GERN stock, worth $123,478. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,950
Holding current value
$123,478
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.3 - $4.44 $154,935 - $208,458
46,950 New
46,950 $166 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $994M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Jain Global LLC Portfolio

Follow Jain Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jain Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jain Global LLC with notifications on news.